Latest Financial Position News

Tambourah Metals reports significant high-grade gold assay results from its Pilbara projects and secures government grants to accelerate drilling programs across multiple prospects.

Bass Oil Limited reported a 27% drop in quarterly revenue amid natural production declines but highlighted promising developments in its Kiwi gas field project in the Cooper Basin.

Manhattan Corporation has secured a pivotal Farm-In Agreement with Novo Resources for its Tibooburra Gold Project and gained surface access to progress drilling at its Chebogue Lithium Project in Canada, underpinning its exploration ambitions.

Alvo Minerals reports a 7.2Mt copper-equivalent resource at Palma and promising rare earth element drill results at Ipora, while launching a contracting division to offset costs.

NOVONIX has advanced its position in the battery materials sector with a conditional US$754 million loan commitment from the U.S. Department of Energy and binding offtake agreements with automotive giants Stellantis and PowerCo. These milestones underpin its expansion plans for synthetic graphite production in North America.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.

First Au Limited updates on its Victorian and Western Australian gold exploration projects, announces key board changes, and completes a $325,000 capital raise to support ongoing operations.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.

Rubix Resources has identified significant untested chargeability anomalies at its Paperbark project, submitting applications for co-funding to drill these promising targets while progressing exploration across its diversified portfolio.

Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.

C29 Metals closes December quarter with $2.56 million cash and key drilling approvals for its Ulytau uranium project, but faces a significant hurdle after Ministerial refusal to transfer ownership of its Kazakhstan tenement.